What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His primary areas of study are Breast cancer, Internal medicine, Oncology, Cancer and Cancer research.
His Breast cancer research incorporates elements of Gene expression profiling, Metastasis and Disease, Pathology.
Patrice Viens has included themes like Gastroenterology, Surgery and Immunology in his Internal medicine study.
The study incorporates disciplines such as Clinical trial, Survival rate, Metastatic breast cancer, Proportional hazards model and Radiation therapy in addition to Oncology.
His study in Cancer is interdisciplinary in nature, drawing from both Nausea and Bioinformatics.
His Cancer research research incorporates themes from DNA microarray, Gene expression, Stem cell, Surgical oncology and Tissue microarray.
His most cited work include:
- ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome (3056 citations)
- Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. (949 citations)
- A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses (660 citations)
What are the main themes of his work throughout his whole career to date?
Patrice Viens mostly deals with Internal medicine, Oncology, Breast cancer, Chemotherapy and Surgery.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Pathology.
As a part of the same scientific study, Patrice Viens usually deals with the Oncology, concentrating on Docetaxel and frequently concerns with Epirubicin and Febrile neutropenia.
His biological study spans a wide range of topics, including Cancer research, Metastasis, Bioinformatics and Gene expression profiling.
Patrice Viens combines subjects such as Survival rate and Adjuvant with his study of Chemotherapy.
He has included themes like Carcinoma and Bone marrow in his Surgery study.
He most often published in these fields:
- Internal medicine (65.43%)
- Oncology (51.74%)
- Breast cancer (45.87%)
What were the highlights of his more recent work (between 2013-2021)?
- Oncology (51.74%)
- Internal medicine (65.43%)
- Breast cancer (45.87%)
In recent papers he was focusing on the following fields of study:
Patrice Viens spends much of his time researching Oncology, Internal medicine, Breast cancer, Cancer and Inflammatory breast cancer.
His Oncology study combines topics from a wide range of disciplines, such as Immunohistochemistry, Pathology, Trastuzumab, Chemotherapy and Metastatic breast cancer.
His Breast cancer research includes themes of Predictive value of tests, Confidence interval, Concomitant, Primary tumor and Surrogate endpoint.
His research in Cancer focuses on subjects like Basal, which are connected to Downregulation and upregulation.
The study incorporates disciplines such as Neoadjuvant therapy, Cancer research, Surgery, Immunology and Bevacizumab in addition to Inflammatory breast cancer.
His studies deal with areas such as Transcriptome, Targeted therapy and Gene expression profiling as well as Cancer research.
Between 2013 and 2021, his most popular works were:
- Prognostic and predictive value of PDL1 expression in breast cancer (265 citations)
- Prognostic and predictive value of PDL1 expression in breast cancer (265 citations)
- Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. (109 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Patrice Viens focuses on Internal medicine, Oncology, Breast cancer, Cancer and Chemotherapy.
His Performance status study, which is part of a larger body of work in Oncology, is frequently linked to Context, bridging the gap between disciplines.
Patrice Viens interconnects Immunohistochemistry, Surrogate endpoint, Immunology and Pathology in the investigation of issues within Breast cancer.
His Cancer study incorporates themes from Basal and In vivo.
His study looks at the relationship between Chemotherapy and topics such as Adjuvant, which overlap with Pathological and Univariate analysis.
His research integrates issues of Bevacizumab and Gene expression profiling in his study of Inflammatory breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
